Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002039
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
Sponsor:
Astra USA
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
Status:
COMPLETED
Status Verified Date:
1991-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and efficacy of foscarnet induction therapy for treatment of AIDS patients experiencing their first episode of cytomegalovirus CMV retinitis To evaluate the safety and efficacy of three different foscarnet maintenance therapy regimens To determine the pharmacokinetics of intermittent administration of foscarnet with or without concomitant administration of zidovudine AZT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 88-FOS-01 | None | None | None |